| Application no. and date | 17194619.7 (espacenet) (Federated) (European Patent Register), 20090417 | | Patent/reg. no. and date | DK/EP 3320912, 20210331 | | Publication date | 20180516 | | Priority no. and date | DK 200800565, 20080417 | | EP pub. no. and date |
EP 3320912 20180516 | | Effective date | | | Applicant/owner | IO BIOTECH ApS, c/o COBIS
Ole Maaløes Vej 3, 2200 København N, DK | | Applicant ref. no. | V53199DK00 | | Inventor | Andersen, Mads Hald,
Hegnsvej 61, 2850 Nærum, DK,
STRATEN, Per Thor, Catherine Booths Vej 17, 2650 Hvidovre, DK | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 38/08 (2019.01) , A61K 38/10 (2006.01) , A61K 38/17 (2006.01) , A61K 38/19 (2006.01) , A61K 38/20 (2006.01) , A61K 38/44 (2006.01) , A61K 39/00 (2006.01) , A61K 45/06 (2006.01) , C12N 9/02 (2006.01) | | Title | Indoleamin-2, 3-dioxygenasebaseret immunterapi | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
